June 5, 2025
TOPLINE: A new diabetes-specific 10-item screening tool demonstrated excellent performance in detecting binge eating disorder in both patients with type 1 diabetes (T1D) and those with […]
June 5, 2025
TOPLINE: One third of patients with type 2 diabetes (T2D) treated with metformin plus one of four common glucose-lowering drugs (insulin glargine U-100, glimepiride, liraglutide, or […]
June 5, 2025
A new risk model may help identify which patients with chronic kidney disease (CKD) and diabetes are more likely to develop hyperkalemia, granting physicians more confidence […]
June 3, 2025
TOPLINE: In patients with primary hypothyroidism receiving a stable dose of levothyroxine, thyroid-dependent quality of life (QOL) was driven by psychological factors, including somatosensory amplification and […]
June 3, 2025
LOS ANGELES (Reuters) -American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in its use for young […]
June 2, 2025
(Reuters) -Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in combination with […]
June 2, 2025
A new consensus report from the American Diabetes Association (ADA) provides a practice-oriented framework for screening and managing metabolic dysfunction–associated steatotic liver disease (MASLD) in people […]
May 29, 2025
TOPLINE: Compared with standard-of-care practices according to the European Association for the Study of Diabetes (EASD) and American Diabetes Association (ADA) consensus report, telemonitoring with continuous […]
May 29, 2025
TOPLINE: The prevalence of concurrent hypertension and type 2 diabetes (T2D) doubled from approximately 6% to 12% in the United States between 1999 and 2018, with […]